文献速递白血病

低二倍体对儿童急性髓系白血病生存的不利影响:I-BFM研究组协作研究

Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: an I-BFM Study Group collaboration.
PubMed 文献 · Blood Adv · 2023-01-01

该回顾性队列研究纳入2000至2015年14个儿童AML组的初诊低二倍体核型患儿,低二倍体发生率为1.3%(81例),5年无事件生存率和总生存率分别为34%和52%;MN≤44组较MN=45组EFS和OS更差,调整后HR分别为4.9和6.1;首次完全缓解期异基因干细胞移植未改善不良结局。

要点

  • 儿童AML中低二倍体发生率为1.3%(81例),5年EFS和OS分别为34%和52%。
  • MN≤44组较MN=45组EFS和OS更差,调整后HR分别为4.9(P=.001)和6.1(P=.003)。
  • 首次完全缓解期异基因干细胞移植未改善低二倍体的不良结局,调整后OS的HR为1.5(P=.42)。

核心结论

  • 儿童低二倍体AML是罕见亚组,即使接受首次完全缓解期干细胞移植预后仍较差。

研究设计与样本

  • 回顾性队列研究,纳入2000至2015年国际柏林-法兰克福-明斯特(I-BFM)框架下14个儿童AML组的初诊AML且低二倍体核型、年龄低于18岁的患儿。
  • 排除标准包括体质性低二倍体、7号染色体单体、复合核型以及伴性染色体丢失的t(8;21)。

主要发现

  • 低二倍体发生率为1.3%(81例),众数染色体数为45者66例、44者10例、43者5例。
  • 最常丢失的染色体为9号染色体和性染色体。
  • 低二倍体队列5年无事件生存率为34%,总生存率为52%。
  • MN≤44组(15例)EFS为21%、OS为33%,MN=45组(66例)EFS为37%、OS为56%。
  • 单体核型或9号染色体单体者OS尤其差,分别为43%和15%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hypodiploidy, defined as modal numbers (MNs) 45 or lower, has not been independently investigated in pediatric acute myeloid leukemia (AML) but is a well-described high-risk factor in pediatric acute lymphoblastic leukemia. We aimed to characterize and study the prognostic impact of hypodiploidy in pediatric AML. In this retrospective cohort study, we included children below 18 years of age with de novo AML and a hypodiploid karyotype diagnosed from 2000 to 2015 in 14 childhood AML groups from the International Berlin-Frankfurt-Münster (I-BFM) framework. Exclusion criteria comprised constitutional hypodiploidy, monosomy 7, composite karyotype, and t(8;21) with concurring sex chromosome loss. Hypodiploidy occurred in 81 patients (1.3%) with MNs, 45 (n = 66); 44 (n = 10) and 43 (n = 5). The most frequently lost chromosomes were chromosome 9 and sex chromosomes. Five-year event-free survival (EFS) and overall survival (OS) were 34% and 52%, respectively, for the hypodiploid cohort. Children with MN≤44 (n = 15) had inferior EFS (21%) and OS (33%) compared with children with MN = 45 (n = 66; EFS, 37%; OS, 56%). Adjusted hazard ratios (HRs) were 4.9 (P = .001) and 6.1 (P = .003). Monosomal karyotype or monosomy 9 had particular poor OS (43% and 15%, respectively). Allogeneic stem cell transplantation (SCT) in first complete remission (CR1) (n = 18) did not mitigate the unfavorable outcome of hypodiploidy (adjusted HR for OS was 1.5; P = .42). We identified pediatric hypodiploid AML as a rare subgroup with an inferior prognosis even in the patients treated with SCT in CR1.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Hammer ASB, Juul-Dam KL, Sandahl JD, et al. Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: an I-BFM Study Group collaboration. Blood Adv. 2023. PMID: 36332007. doi:10.1182/bloodadvances.2022008251

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。